Ads
-
Related paper
- PATHOGENETIC THERAPY OF PATIENTS WITH CHRONIC HEPATITIS C WHOM INTERFERONTHERAPY IS CONTRAINDICATED
- Serum Anti-Interferon Alpha Antibodies in Chronic Hepatitis C Patients Treated with Pegylated Interferon Alpha Containing Therapy
- Vitiligo Associated With Pegylated Interferon and Ribavirin Treatment of Patients With Chronic Hepatitis C
- Pegylated Interferon Alfa 2a Treatment in Patients with Chronic Hepatitis B and Genotype D in Jordan
- GAMMA GLUTAMYL TRANSFERASE IN PREDICTION OF E ARLY V IROLOGICAL R ESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY
- Amino Acid Substitution in Hepatitis C Virus Core and Genetic Variation in Interleukin 28? Gene and their Correlation to Interferon Treatment Failure in Chronic HCV Egyptian Patients
- Therapeutic Response of Black Africans in the Treatment of Genotype 2 Chronic Viral Hepatitis c by Pegylated Interferon-ribavirin
- THERAPY OF CYCLOFERON INFLUENCE ON DYNAMICS OF PARAMETERS OF INTERFERON-Α IN SERUM OF THE BLOOD IN PATIENTS WITH ACUTE VIRAL HEPATITIS C
- Occult Hepatitis B Virus infection in a cohort of patients with chronic Hepatitis C
- THE STRUCTURE OF VIRAL HEPATITIS IN THE LVIV REGION IN THE YEARS OF 2000- 2010 AND PREVALENCE OF PERIODONTAL PATHOLOGY IN PATIENTS WITH CHRONIC HEPATITIS C